The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016.
Epidemiology
Mycoplasma
paediatrics
pneumonia
Journal
Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
entrez:
1
8
2019
pubmed:
1
8
2019
medline:
26
3
2020
Statut:
ppublish
Résumé
Paediatric Mycoplasma pneumoniae pneumonia (MPP) is a major cause of community-acquired pneumonia in China. Data on epidemiology of paediatric MPP from China are little known. This study retrospectively collected data from June 2006 to June 2016 in Beijing Children's Hospital, Capital Medical University of North China and aims to explore the epidemiological features of paediatric MPP and severe MPP (SMPP) in North China during the past 10 years. A total of 27 498 paediatric patients with pneumonia were enrolled. Among them, 37.5% of paediatric patients had MPP. In this area, an epidemic took place every 2-3 years at the peak, and the positive rate of MPP increased during these peak years over time. The peak age of MPP was between the ages of 6 and 10 years, accounting for 75.2%, significantly more compared with other age groups (χ2 = 1384.1, P < 0.0001). The epidemics peaked in September, October and November (χ2 = 904.9, P < 0.0001). Additionally, 13.0% of MPP paediatric patients were SMPP, but over time, the rate of SMPP increased, reaching 42.6% in 2016. The mean age of paediatric patients with SMPP (6.7 ± 3.0 years old) was younger than that of patients with non-SMPP (7.4 ± 3.2 years old) (t = 3.60, P = 0.0001). The prevalence of MPP and SMPP is common in China, especially in children from 6 to 10 years old. Paediatric patients with SMPP tend to be younger than those with non-SMPP. MPP outbreaks occur every 2-3 years in North China. September, October and November are the peak months, unlike in South China. Understanding the epidemiological characteristics of paediatric MPP can contribute to timely treatment and diagnosis, and may improve the prognosis of children with SMPP.
Identifiants
pubmed: 31364532
pii: S0950268819000839
doi: 10.1017/S0950268819000839
pmc: PMC6518602
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e192Références
Epidemiol Infect. 2001 Oct;127(2):365-7
pubmed: 11693516
Pediatr Int. 2002 Oct;44(5):510-2
pubmed: 12225550
Epidemiol Infect. 2006 Jun;134(3):548-55
pubmed: 16316495
J Paediatr Child Health. 2005 Dec;41(12):671-6
pubmed: 16398873
Braz J Infect Dis. 2007 Oct;11(5):507-14
pubmed: 17962878
Jpn J Infect Dis. 2007 Nov;60(6):352-4
pubmed: 18032833
Jpn J Infect Dis. 2007 Nov;60(6):370-3
pubmed: 18032837
J Infect. 2008 May;56(5):326-31
pubmed: 18420275
Respir Med. 2008 Dec;102(12):1762-8
pubmed: 18703327
Arch Pediatr. 2008 Nov;15(11):1630-6
pubmed: 18835701
Thorax. 2009 Jun;64(6):507-11
pubmed: 19318345
Diagn Microbiol Infect Dis. 2010 Aug;67(4):355-8
pubmed: 20638604
Cancer Lett. 2011 Jun 28;305(2):263-78
pubmed: 21470769
World J Pediatr. 2011 Aug;7(3):240-4
pubmed: 21822990
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Jun;25(3):224-6
pubmed: 21977599
Zhonghua Er Ke Za Zhi. 2013 Oct;51(10):745-52
pubmed: 24406226
N Engl J Med. 2015 Feb 26;372(9):835-45
pubmed: 25714161
J Infect Dis. 1979 Jun;139(6):681-7
pubmed: 448195
Scand J Infect Dis. 1971;3(1):51-4
pubmed: 4938756